These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6483167)

  • 1. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ; Yanai J; Iser C; Klawans H
    Neuropsychobiology; 1984; 11(2):94-7. PubMed ID: 6483167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study.
    Feigenbaum JJ; Howard SG
    Life Sci; 1997; 60(19):1659-68. PubMed ID: 9129121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible DA agonist properties of naloxone.
    Feigenbaum J; Yanai J; Blass R
    Int J Neurosci; 1982 Nov; 17(3):139-44. PubMed ID: 6302020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens.
    Hooks MS; Jones DN; Justice JB; Holtzman SG
    Pharmacol Biochem Behav; 1992 Aug; 42(4):765-70. PubMed ID: 1513859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine.
    Yamada S; Kojima H; Yokoo H; Tsutsumi T; Takamuki K; Anraku S; Nishi S; Inanaga K
    Biol Psychiatry; 1988 Aug; 24(4):399-408. PubMed ID: 3408757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF; Masserano JM; Weiner N
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study.
    Feigenbaum JJ; Howard SG
    Neurosci Lett; 1997 Mar; 224(1):71-4. PubMed ID: 9132694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
    Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW; Johnson KM
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and chronic administration of cocaine on striatal uptake, compartmentalization and release of [3H]dopamine.
    Yi SJ; Johnson KM
    Neuropharmacology; 1990 May; 29(5):475-86. PubMed ID: 2356003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
    Becker JB; Cha JH
    Behav Brain Res; 1989 Nov; 35(2):117-25. PubMed ID: 2818831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.